ABSTRACT -Sixteen patients with sellar tumors that were treated surgically and who had pre-operative somatotrophic and corticotrophic function deficits were submitted to pre-and early post-operative insulin tolerance tests (ITTs). Seven patients had non-functioning adenomas, 5 had prolactinomas, 3 had craniopharyngioma and 1 had cordoma of the clivus. All patients had macro-tumors and none received radiotherapy within the studied period. Seven patients had GH, 4 had Cortisol and 5 had both GH/cortisol function pre-operative deficit. Five patients with isolated GH, 4 with isolated Cortisol and 3 with both GH/cortisol deficiencies showed a postoperative functional recovery. New Cortisol secretion deficits were observed in 2 patients postoperatively and both required long-term steroid replacement. These data suggest that preoperative endocrine deficits may be reversible after surgical decompression of the sellar region and that new endocrine deficits are rarely seen after surgery. All such patients should be tested postoperatively from an endocrinological point of view to reevaluate the need for replacement therapies.
apoplexy 1,211,13,lli19 . If hypothalamic or pituitary tissue has been destroyed, recovery of normal function is unlikely, and lifelong hormone-replacement therapy is required. However, partial or complete recovery of pituitary function occurred in the majority of the patients (65%) with non-functioning pituitary adenomas submitted to transesphenoidal surgery studied by Arafah 1 ; thyroidal function improved in 57%, gonadal function in 32% and pituitary-adrenal function in 38% of the patients 1 . Somatotrophic function had fully recovered in only a small number of patients postoperatively (0-27%) 1, 18, 19 . However, in most of these studies the adult GH deficiency has been defined based on studies in children and the wide variation in the "cut-off of peak GH response to a standard provocative test could have contributed to this small rate of somatotrophic recovery.
The mechanisms by which pituitary tumors cause hypopituitarism include mechanical compression of normal pituitary tissue by the tumor, impaired blood flow to the normal tissue, and interference with the delivery of hypothalamic regulating hormones through the hypothalamichypophysial portal system.
In this paper we analised the effects of transesphenoidal surgery on somatotrophic and corticotrophic deficiencies seen in patients with sellar tumors and elaborated on the usefulness of re-evaluating these patients from an endocrinological point of view after surgery. Serum GH concentrations were measured by immunoradiometric methods, using a commercially available kit from Pharmacia (Uppsala, Sweden). The limit of detection of GH was 0.5 ng/ml, and the intra-and interassay coefficients of variation were 7.3% and less than 10%, respectively. The samples from the two tests (pre -and postoperative) from each patient were measured in the same assay. GHd was diagnosed if peak GH level did not reach a value of 5.0 ng/ml after insulin-induced hypoglycaemia (< 45 mg/dL) 12 . Plasma concentrations of Cortisol were measured by radioimmunoassay, using kits from Baxter-Clinical (Stillwater, MA, USA), and the intra-and interassay coefficients of variation were 7.0% and 9.0%, respectively. The diagnosis of Cortisol deficiency was established if the peak Cortisol level was lower than 18 Mg/dL following hypoglycemia 3 . The other hormonal measurements (T3, T4, TSH, LH, FSH and PRL) were performed by radioimmunoassay, using commercially available kits, which have interassay coefficients of variation below 12% (data not presented).
METHODS
The Wilcoxon test was used to compare the peak GH and Cortisol levels in the pre-and postoperative evaluations. The results were expressed in mean ± SEM values. A "p" value lower than 0.05 was considered statistically significant.
RESULTS
All patients got effective ITTs (glicemia below 45 mg/dl). Twelve patients had GHd (7 with isolated GHd and 5 with GHd plus Cortisol deficiency) and 4 had isolated Cortisol deficiency. The preoperative mean GH peak for the 12 patients with GHd was 1.5±0.2 ng/ml (range: 0.5-3.1). Postoperatively, 7 (58.3%) of these patients showed GH peaks higher than those observed preoperatively (11.6±2.8 ng/ml)(p=0.02), being between 5 to 7 ng/ml in 3 patients and above 7 ng/ ml in the others (Fig 1) . Five out of the 7 patients with isolated GHd in the preoperative evaluation recovered GH secretion after surgery. The patients with Cortisol deficiency had a mean Cortisol peak of 9.5±1.5 ug/dl preoperatively. Six of these patients (67%) disclosed a normal Cortisol response during the ITT after surgery (peak Cortisol = 23.4±2.1 ug/dl)(p = 0.03) (Fig 2) . Three of the 5 patients with GH plus Cortisol deficiencies preoperatively recovered some endocrine function after surgical treatment: 1 patient with prolactinoma recovered GH and Cortisol secretion and the other 2 recovered only one endocrine function (GH or Cortisol secretion).
Patients with isolated GH or Cortisol deficiencies preoperatively had an 82% recovery rate after surgical treatment (9/11). In those with both GH and Cortisol deficiencies before surgery, the rate of recovery of at least one of the pituitary axis was 60% (3/5).
Postoperative impaired Cortisol secretion was observed in 2 patients with isolated
GHd preoperatively and both required chronic steroid replacement therapy. Surgery did not induce GHd in those patients with isolated Cortisol deficiency preoperatively. Table 1 shows the distribution of the preoperative hormonal deficiencies and the endocrine outcome after surgery. Five of the 7 patients with nonfunctioning macroadenomas recovered GH or Cortisol secretion postoperatively. Only 1 of the 5 patients with prolactinoma remained with partial Cortisol deficiency postoperatively and did not require chronic replacement therapy. Prolactin levels were reduced in all patients with prolactinoma after surgery and were normal in 3. The other 2 had prolactin levels of 1030 and 550 postoperatively. It was not possible to establish any statistical difference on the endocrine recovery rate between patients with prolactinoma with normal or abnormal postoperative prolactin levels (small "n"). AH patients with craniopharyngioma disclosed GHd before surgery and none had Cortisol deficiency. One of them obtained a GH secretion recovery (with peak GH of 19.0 and 14.0 ng/ml in two postoperative ITT) but in 2 there was a worsening of the Cortisol response to the ITT. The patient with cordoma recovery its GHd after surgical treatment.
DISCUSSION
GH release after an insulin-induced hypoglycaemia may be impaired in adult patients with sellar tumors. This can also occur after irradiation or surgery of this region 6 12 have demonstrated that the ITT is extremely accurate in differentiating subjects with organic GHd from normal matched subjects. In Hoffman's series, GHd adults had a GH peak lower than 3.1 ng/ml during the ITT, which is significantly lower than the control subjects that had GH peaks higher than 5.0 ng/ml. Furthermore, GH release after the ITT is not reduced in idiopatic hyperprolactinemia 9 . Although some authors would consider the diagnosis of adult onset GHd in all patients with a GH peak lower than 7-10 ng/ml, the mean GH peak seen in most of their patients were lower than 3.5 ng/ml, suggesting that in this disorder the GH peak after ITT is very low 17, 22 ' 25 . We have accepted Hoffman's criteria for the diagnosis of adult-onset GHd in this paper. Surprisingly, our data showed that 58.3% of the patients with GHd preoperatively had an improvement in GH secretion (GH peak higher than 5.0 ng/ml) postoperatively. This rate of recovery after surgery is higher than previously reported 1, 1819 . Arafah 1 reported a high incidence of GHd (near 100%) preoperatively in patients with nonfunctioning pituitary adenoma and that GH secretion's recovery was not frequent postoperatively (15%). The cutoff value for the diagnosis of GHd in our study (5.0 ng/ml) was lower than that used in their study (8.0 ng/ml) and this could have influenced our postoperative results. The same author 1 had observed that the mean tumor size in patients recovering pituitary function was significantly smaller than that in patients with persistent hypopituitarism. Unfortunately, it is often difficult to compare different series in terms of tumor volume and size.
Many authors 5,8,16 ' 18 ' 24 .have demonstrated that preoperative adenohypophyseal dysfunction was not reversed by surgery in most of patients with craniopharyngioma and that most of them experienced new endocrinological deficits after surgery. However, Barreca et al. 4 reported GH secretion recovery postoperatively in patients with craniopharyngioma. One of our patients with craniopharyngioma also recovered the somatotrophic function postoperatively.
Pituitary-adrenal function improved in 67% of our patients with preoperative ACTH deficiency. Immediate recovery of pituitary-adrenal function has been described previously in approximately 65% of the patients with macroadenomas 3 . Pituitary ACTH secretion deficits or impaired ACTH reserve is not as frequent as GH deficiency preoperatively in patients with sellar tumors. ACTH secretion deficiency has been described in 5-62% of the patients with macroadenomas or craniopharyngioma 11819 . Moreover, postoperative pituitary-adrenal deficiency is not so frequent 313 . Two of our patients with craniopharyngioma developed permanent ACTH deficiency postoperatively and one patient with prolactinoma remained with partial deficiency that did not require steroid replacement for a long time.
The pathophysiological mechanisms causing partial or total hypopituitarism in patients with sellar tumors are not yet completely understood. The recovery of pituitary function in most patients after transesphenoidal surgery suggest that there is viable pituitary tissue preoperatively, which is transiently unable to secrete, possibly as a result of altered hypothalamic regulation'-3 .
It is possible to demonstrate some preserved pituitary function with the use of synthetic hypothalamic peptides like GHRH, TRH and GnRH in patients with hypothalamic-pituitary disconnection due to pituitary stalk transection or tumors of this area 14, 20 . It has been showed that the preoperative serum prolactin level is higher in patients who recovered pituitary function after adenomectomy than in those who did not 1, 3 . High intrasellar pituitary tissue pressure and pituitary stalk compression were previously demonstrated 15 and could be the most important factor to induce pituitary deficiencies by comprimising blood flow through the portal vessels. Surgery with removal of the tumor could induce decompression of the pituitary stalk and reduce intrasellar pituitary pressure, allowing for the recovery of some or all hypothalamic-pituitary axis.
In summary, this study demonstrated that in patients with sellar tumors preoperative Cortisol and GH deficiencies may be reversible after surgical decompression and that hormonal deficiency is not frequently induced by surgery. All such patients should be tested postoperatively from an endocrinological point of view to reevaluate the need for replacement therapies.
